PCSK6 exacerbates Alzheimer's disease pathogenesis by promoting MT5-MMP maturation
In this study, we reported that the expression of PCSK6 was significantly increased in the brain tissues of postmortem AD patients and APP23/PS45 transgenic AD model mice, as well as N2AAPP cells. Genetic knockdown of PCSK6 reduced amyloidogenic processing of APP in N2AAPP cells by suppressing the activation of membrane-type 5-matrix metalloproteinase (MT5-MMP), referred to as η-secretase. We further found that PCSK6 cleaved and activated MT5-MMP by recognizing the RRRNKR sequence in its N-terminal propeptide domain in N2A cells. The mutation or knockout of this cleavage motif prevented PCSK6 from interacting with MT5-MMP and performing cleavage. Importantly, genetic knockdown of PCSK6 with adeno-associated virus (AAV) reduced Aβ production and ameliorated hippocampal long-term potentiation (LTP) and long-term spatial learning and memory in APP23/PS45 transgenic mice. Taken together, these results demonstrate that genetic knockdown of PCSK6 effectively alleviate AD-related pathology and cognitive impairments by inactivating MT5-MMP, highlighting its potential as a novel therapeutic target for AD treatment.PMID:38216110 | DOI:10.1016/j.expneurol.2024.114688
Source: Experimental Neurology - Category: Neurology Authors: Mingliang Xu Junjie Li Lei Xia Yehong Du Bin Wu Xiuyu Shi Na Tian Yayan Pang Lilin Yi Mulan Chen Weihong Song Zhifang Dong Source Type: research
More News: Adenoviruses | Alzheimer's | Brain | Calcium | Genetics | Learning | Neurology | Pathology | Study | Universities & Medical Training